000 01390 a2200385 4500
005 20250515154804.0
264 0 _c20100427
008 201004s 0 0 eng d
022 _a1878-5832
024 7 _a10.1016/j.drudis.2008.12.010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan Eden, Willem
245 0 0 _aBiologics and postbiologics: novel immunotherapeutics for the induction and maintenance of remission.
_h[electronic resource]
260 _bDrug discovery today
_cJan 2010
300 _a71-7 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAutoimmune Diseases
_xdrug therapy
650 0 4 _aBiological Products
_xadverse effects
650 0 4 _aDisease Models, Animal
650 0 4 _aDrug Delivery Systems
_xmethods
650 0 4 _aDrug Discovery
_xmethods
650 0 4 _aEpitopes
_xdrug effects
650 0 4 _aHumans
650 0 4 _aImmunologic Factors
_xadverse effects
650 0 4 _aModels, Immunological
650 0 4 _aRemission Induction
650 0 4 _aT-Lymphocytes
_xdrug effects
650 0 4 _aTranslational Research, Biomedical
_xmethods
700 1 _aLisse, Jeffrey
700 1 _aPrakken, Berent
700 1 _aAlbani, Salvatore
773 0 _tDrug discovery today
_gvol. 15
_gno. 1-2
_gp. 71-7
856 4 0 _uhttps://doi.org/10.1016/j.drudis.2008.12.010
_zAvailable from publisher's website
999 _c18608964
_d18608964